Skip to main content
Greenfern Logo

Greenfern

Greenfern has partnered with a NZ distribution partner who were the first to successfully sell cannabis into Europe from NZ. The partner has established a two year binding agreement to purchase the majority of the medicinal cannabis that Greenfern can produce.

In addition to this, they are fielding inquiries from a number of interested vendors in both New Zealand and internationally who are seeking to purchase Greenfern’s medicinal cannabis. Over the next year Greenfern has a sales target of $1.1-$1.8M as its distribution partner proceeds to penetrate the lucrative European cannabis market.

Likewise, Greenfern has been approached by distribution partners in NZ, Australia, and the UK. With the new international sales channels and cultivation production currently underway we expect to see an increase in the share price in the next 12 months.

Greenfern now has over 260m2 of fully automated 100% indoor cultivation space with the ability to produce up to 450-550kg of premium medical flower per annum. To match the energy requirements of the expanded production facilities, Greenfern plans an expansion of their hydroelectric power plant from 250kw to approximately 850kw.

Choose Your Investment Deal


This will close in 0 seconds